Cleveland BioLabs
Cleveland BioLabs
Employees:
20
Market Cap:
$19.36 million
Revenue:
$1.98 million
5 Year Trend:
11.4%
Net Income:
$-5.62 million
Stock:
CBLI

Cleveland BioLabs, Inc. (Nasdaq: CBLI) is a clinical-stage biotechnology company with a focus on oncology development. It specializes in research and development of products with the potential to treat cancer and protect against death following acute radiation syndrome. Wikipedia

Cleveland BioLabs
Are you from Cleveland BioLabs?

Cleveland BioLabs, Inc. (Nasdaq: CBLI) is a clinical-stage biotechnology company with a focus on oncology development. It specializes in research and development of products with the potential to treat cancer and protect against death following acute radiation syndrome. Wikipedia

Employees:
20
Market Cap:
$19.36 million
Revenue:
$1.98 million
5 Year Trend:
11.4%
Net Income:
$-5.62 million
Stock:
CBLI

Jobs at Cleveland BioLabs

There are no jobs at the current time